全球病理学设备市场

预计到 2030 年全球病理设备市场规模将达 81 亿美元

全球病理学设备市场规模预计在2024年为60亿美元，预计到2030年将达到81亿美元，在分析期内（2024-2030年）的复合年增长率为5.1%。临床化学技术是本报告分析的细分市场之一，预计其复合年增长率为6.0%，到分析期结束时规模将达到33亿美元。免疫检测技术领域在分析期间的复合年增长率预计为5.7%。

美国市场规模估计为 16 亿美元，中国市场预期复合年增长率为 9.3%

美国病理设备市场规模预计2024年达到16亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到17亿美元，在2024-2030年的分析期间内，复合年增长率为9.3%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为2.1%和4.0%。在欧洲，预计德国市场的复合年增长率为3.0%。

全球病理学设备市场—主要趋势与驱动因素摘要

病理学仪器如何发展以满足精准诊断的需求？

病理学仪器处于医学诊断生态系统的前沿，是疾病检测、分类和治疗监测的支柱。精准医疗、微创诊断和早期疾病识别的转变正在推动一系列病理学仪器的创新，包括组织病理学仪器、细胞学系统、免疫组织化学平台、数位病理扫描仪和自动切片处理器。这些工具在实现高通量、高重现性和高分析灵敏度的测试工作流程方面发挥着至关重要的作用。

由于组织病理学仍然是癌症诊断和分期的黄金标准，对自动化组织处理器、切片机、包埋中心和染色系统的需求比以往任何时候都更重要。液基细胞学 (LBC) 系统和自动化玻片製备设备等细胞学设备在癌症筛检计画中越来越受欢迎，尤其是在子宫颈癌和呼吸道癌的筛检中。同时，免疫组织化学 (IHC) 已被广泛用于肿瘤学中的生物标记检测，而基于抗体的染色系统正被整合到实验室自动化流程中，以确保一致性和扩充性。

此外，数位病理学的兴起正在将基于玻片的诊断从类比方式转变为以影像为中心的平台。全玻片成像 (WSI) 设备将传统的玻片转换为高解析度的数位格式，然后由人工智慧软体进行分析，以确定细胞形态、肿瘤分级和异常检测。这种数位化促进了病理学家之间的远距协作，减少了观察者之间的差异，并支持医疗资源匮乏的农村地区进行远距病理诊断。随着医院日益融入综合医疗体系，对病理设备互通性和集中诊断的需求也日益增长。

哪些创新正在颠覆传统的病理学工作流程？

数位转型正在透过将成像、分析和云端基础设施整合到传统工作流程中，重新定义病理学设备格局。能够以 40 倍放大倍率撷取影像的全切片扫描器越来越多地配备了快速自动对焦、用于深度解析度的 Z 轴堆迭以及用于大样本量的批量扫描功能。这些仪器与 AI/ML 演算法相辅相成，有助于量化组织特征、标记潜在异常并产生自动诊断提案，简化了病理学家的决策流程。

自动化是另一个关键的颠覆性因素。从自动化试剂和通讯协定选择的智慧染色平台开始，病理实验室正在最大限度地减少人工干预，降低週转时间和错误率。模组化实验室自动化系统现已将样本追踪、条码读取器、液体处理器和载玻片盖片滑行器连接成一个无缝的诊断流程，使实验室能够在不影响诊断准确性的情况下实现更快的通量。与实验室资讯系统 (LIS) 的整合进一步确保了即时追踪、合规性和高效报告。

此外，伴随诊断的兴起也影响着设备的发展。製药公司和诊断设备製造商正在合作建立病理学平台，以支援基于组织的生物标记检验，从而实现有针对性的标靶治疗化肿瘤治疗。多重免疫组化 (IHC) 和原位杂合反应(ISH) 工具正在帮助实验室在单张玻片上检测多种生物标记物，从而节省组织样本并提高诊断产量。这些技术也正在根据 FDA 和 CE 标誌框架进行监管检验，以实现全球临床部署。

哪些最终用户和区域市场正在推动病理设备的需求？

病理设备的主要终端使用者是医院、参考实验室、学术医疗中心和癌症研究机构。大型连锁医院正在迅速采用自动化病理检测平台，以应对日益增长的活检量、缩短报告时间并优化病理人力配置。为多家医疗机构处理检测的中央实验室正在加大对机器人技术和数位病理解决方案的投资，以提高效率并实现远距会诊。

学术机构和癌症中心在下一代设备的早期采用中发挥关键作用，尤其是涉及人工智慧解读和多重免疫组织化学技术的设备。这些中心通常充当新兴技术的检验中心，并为临床和监管核准所需的依证做出贡献。此外，製药研发和委外研发机构(CRO) 正在采用数位病理学平台进行生物标记筛检和药物疗效测试，从而推动临床前市场的成长。

从区域层面来看，北美和西欧凭藉其先进的医疗基础设施、较高的活检量以及对病理诊断的补贴性报销政策，继续保持领先地位。尤其是在美国，有利的医疗保险和医疗补助服务中心（CMS）政策和美国食品药物管理局（FDA）的数位影像指南促进了病理实验室的整合和数位病理学的广泛应用。同时，以中国、印度和韩国为首的亚太地区，由于癌症筛检计画的不断扩大以及公私合作诊断链的扩张，病理学基础设施正在快速成长。拉丁美洲和中东是新兴市场，对三级医疗和癌症诊断的投资正在为设备应用铺平新的道路。

哪些因素推动了全球病理设备市场的成长？

全球病理学设备市场的成长动力源自于慢性病和肿瘤疾病的日益普及、对早期精准诊断的需求、数位病理学和实验室自动化技术的进步，以及全球对个人化医疗的追求。癌症发生率的上升、人口老化以及预防保健意识的不断增强，要求诊断系统能够提供快速、可重复且可操作的结果，从而推动了对先进病理学设备的需求。

全球各地的医疗保健系统正在采用集中式数位化病理学平台，以解决训练有素的病理学家短缺的问题，缩短从检体到报告的时间，并提高诊断品质。同时，病理学与分子诊断和人工智慧分析的日益融合，使临床医生能够从组织样本中获得更深入的洞察，为制定个人化治疗方案铺平道路。这些因素在肿瘤学中尤其重要，因为肿瘤学的治疗效果通常取决于准确的肿瘤分类和生物标记状态。

此外，来自医疗器材公司、创业投资和医疗IT公司的强劲投资正在加速创新和商业化。诊断实验室、高科技公司和製药公司之间的协同开发正在创造适用于下一代医疗保健的解决方案。监管方面的进步，例如数位病理设备的核准和灵活的临床试验要求，正在进一步消除进入障碍。随着数位医学和精准医疗的融合，病理设备已成为现代诊断技术的关键，推动全球市场强劲且持续的扩张。

部分

技术（临床化学、免疫检测、微生物学、分子诊断、其他技术）、应用（药物发现和开发、疾病诊断、法医学诊断、其他应用）、最终用户（製药公司、医院和诊断实验室、其他最终用户）

受访公司范例

• 3DHISTECH
• Abbott Laboratories
• Agilent Technologies
• Beckman Coulter（Danaher）
• Becton, Dickinson and Company（BD）
• Bio-Rad Laboratories
• CellaVision
• ContextVision
• Danaher Corporation
• Epredia（3DHISTECH）
• F. Hoffmann-La Roche AG
• Hamamatsu Photonics
• Hamamatsu Photonics
• Leica Biosystems（Danaher）
• Mikroscan Technologies
• Olympus Corporation
• Ortho-Clinical Diagnostics
• PerkinElmer
• PHC Holdings/Sakura Finetek
• Philips（Digital Pathology）

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 比赛

Global Pathology Devices Market to Reach US$8.1 Billion by 2030

The global market for Pathology Devices estimated at US$6.0 Billion in the year 2024, is expected to reach US$8.1 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Clinical Chemistry Technology, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Immunoassays Technology segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 9.3% CAGR

The Pathology Devices market in the U.S. is estimated at US$1.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 9.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.1% and 4.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.0% CAGR.

Global Pathology Devices Market - Key Trends & Drivers Summarized

How Are Pathology Devices Advancing to Meet the Demands of Precision Diagnostics?

Pathology devices are at the forefront of the medical diagnostics ecosystem, serving as the backbone of disease detection, classification, and therapeutic monitoring. The shift toward precision medicine, minimally invasive diagnostics, and early disease identification is driving innovation across a range of pathology instrumentation, including histopathology equipment, cytology systems, immunohistochemistry platforms, digital pathology scanners, and automated slide processors. These tools play an indispensable role in enabling high-throughput, reproducible, and analytically sensitive laboratory workflows.

Histopathological examination remains the gold standard in cancer diagnostics and disease staging, making the demand for automated tissue processors, microtomes, embedding centers, and staining systems more critical than ever. Cytology devices, including liquid-based cytology (LBC) systems and automated slide preparers, are gaining traction in cancer screening programs, particularly for cervical and respiratory tract cancers. Immunohistochemistry (IHC), meanwhile, has seen significant adoption for biomarker detection in oncology, with antibody-based staining systems being integrated into lab automation chains for consistency and scalability.

Moreover, the advent of digital pathology is transforming slide-based diagnostics from analog to image-centric platforms. Whole-slide imaging (WSI) devices convert traditional glass slides into high-resolution digital formats, which are then analyzed via AI-powered software for cell morphology, tumor grading, and anomaly detection. This digital transition is enabling remote collaboration between pathologists, reducing inter-observer variability, and supporting telepathology for underserved and rural regions. As hospitals consolidate into integrated healthcare systems, the demand for pathology device interoperability and centralized diagnostics continues to rise.

What Technology Innovations Are Disrupting Traditional Pathology Workflows?

Digital transformation is redefining the pathology device landscape by integrating imaging, analytics, and cloud infrastructure into conventional workflows. Whole-slide scanners, capable of capturing images at 40x magnification, are increasingly equipped with high-speed autofocus, z-stacking for depth resolution, and batch scanning capabilities for large sample volumes. These devices are complemented by AI/ML algorithms that assist in quantifying tissue features, flagging potential abnormalities, and generating automated diagnostic suggestions-streamlining the pathologist’s decision-making process.

Automation is another key disruptor. From robotic arms used in sample accessioning to smart staining platforms that auto-select reagents and protocols, pathology labs are minimizing manual intervention to reduce turnaround time and error rates. Modular lab automation systems now link sample tracking, barcode readers, liquid handlers, and slide cover-slippers into a seamless diagnostic pipeline, allowing laboratories to achieve faster throughput without compromising diagnostic accuracy. Integration with Laboratory Information Systems (LIS) further ensures real-time tracking, compliance, and reporting efficiency.

Additionally, the rise of companion diagnostics is influencing device development. Pharmaceutical companies and diagnostics manufacturers are collaborating to build pathology platforms that support tissue-based biomarker validation, enabling targeted therapies and personalized oncology treatments. Multiplex IHC and in situ hybridization (ISH) tools are helping laboratories detect multiple biomarkers on a single slide, increasing diagnostic yield while conserving tissue samples. These technologies are also being validated for regulatory compliance under FDA and CE marking frameworks, making them viable for clinical deployment worldwide.

Which End-Use Settings and Regional Markets Are Driving Demand for Pathology Devices?

Hospitals, diagnostic reference laboratories, academic medical centers, and cancer research institutions represent the primary end-users of pathology devices. Large hospital chains are rapidly adopting automated pathology platforms to accommodate growing biopsy volumes, shorten reporting timelines, and optimize pathology manpower. Centralized labs that process tests for multiple healthcare providers are increasingly investing in robotic and digital pathology solutions to boost efficiency and enable remote consultations.

Academic institutions and cancer centers play a critical role in the early adoption of next-generation devices, particularly those involving AI interpretation and multiplex immunohistochemistry. These centers often serve as validation hubs for emerging technologies and contribute to the evidence base required for clinical and regulatory approvals. Additionally, pharmaceutical R&D and contract research organizations (CROs) are adopting digital pathology platforms for biomarker screening and drug efficacy trials-creating a growing non-clinical market for pathology devices.

Regionally, North America and Western Europe remain dominant due to advanced healthcare infrastructure, high biopsy volumes, and supportive reimbursement for pathology-based diagnostics. The U.S., in particular, is witnessing consolidation of pathology labs and strong uptake of digital pathology due to favorable CMS policies and FDA's digital imaging guidelines. Meanwhile, Asia-Pacific-led by China, India, and South Korea-is experiencing rapid growth in pathology infrastructure as cancer screening programs expand and public-private diagnostic chains scale up operations. Latin America and the Middle East are emerging markets where investments in tertiary care and cancer diagnosis are opening up new pathways for device adoption.

What Factors Are Driving the Growth of the Global Pathology Devices Market?

The growth in the global pathology devices market is driven by the increasing prevalence of chronic and oncological diseases, demand for early and accurate diagnostics, advancements in digital pathology and lab automation, and the global push toward personalized medicine. With rising cancer incidence, aging populations, and greater awareness about preventive health, there is growing pressure on diagnostic systems to deliver fast, reproducible, and actionable results-propelling the demand for advanced pathology devices.

Healthcare systems worldwide are adopting centralized and digitized pathology platforms to address shortages of trained pathologists, reduce sample-to-report time, and improve diagnostic quality. In parallel, the integration of pathology with molecular diagnostics and AI analytics is enabling clinicians to extract deeper insights from tissue samples, paving the way for personalized therapy plans. These factors are particularly relevant in oncology, where treatment efficacy often depends on precise tumor classification and biomarker status.

Furthermore, strong investments from medical device firms, venture capitalists, and healthcare IT companies are accelerating innovation and commercialization. Collaborations between diagnostic labs, tech companies, and pharma players are resulting in co-developed solutions tailored for next-generation healthcare. Regulatory advancements, such as digital pathology device approvals and flexible clinical trial requirements, are further removing entry barriers. As digital and precision medicine converge, pathology devices are set to become indispensable to modern diagnostics, driving strong and sustained global market expansion.

SCOPE OF STUDY:

The report analyzes the Pathology Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology, Other Technologies); Application (Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application, Other Applications); End-User (Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 37 Featured) -

• 3DHISTECH
• Abbott Laboratories
• Agilent Technologies
• Beckman Coulter (Danaher)
• Becton, Dickinson and Company (BD)
• Bio-Rad Laboratories
• CellaVision
• ContextVision
• Danaher Corporation
• Epredia (3DHISTECH)
• F. Hoffmann-La Roche AG
• Hamamatsu Photonics
• Hamamatsu Photonics
• Leica Biosystems (Danaher)
• Mikroscan Technologies
• Olympus Corporation
• Ortho-Clinical Diagnostics
• PerkinElmer
• PHC Holdings / Sakura Finetek
• Philips (Digital Pathology)

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Pathology Devices - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Cancer Burden Throws the Spotlight on Advanced Pathology Diagnostic Equipment
  • Automation and Digital Pathology Trends Drive Demand for High-Throughput Devices
  • Integration of Artificial Intelligence in Histopathology Spurs Workflow Efficiency and Accuracy
  • Expansion of Precision Medicine and Molecular Diagnostics Strengthens Business Case for Pathology Platforms
  • Increased Adoption of Digital Slide Scanners and Image Analysis Systems Propels Market Growth
  • Growth in Biopsy Testing and Early Disease Detection Accelerates Use of Specialized Pathology Instruments
  • Integration of LIS and EMR Systems Enhances Data Interoperability for Pathology Labs
  • Global Shortage of Pathologists Promotes Use of AI-Driven Diagnostic Devices
  • Demand for Remote Pathology and Telemedicine Platforms Expands Use of Digital Diagnostic Equipment
  • Government Funding for Cancer Screening and Laboratory Modernization Supports Market Penetration
  • Regulatory Approvals for AI-Based Diagnostic Algorithms Spur Commercialization of Smart Devices
  • Advancements in Multi-Modality Imaging and Staining Technologies Enhance Device Functionality
  • Rising Geriatric Population Drives Screening Volume for Age-Linked Diseases and Tumors
  • Focus on Lab Efficiency and Turnaround Time Reductions Fuels High-Speed Device Adoption
  • Increased Sample Volume in Oncology and Infectious Disease Diagnostics Boosts Equipment Demand
  • Growth in Clinical Research and Biobank Development Expands Pathology Device Applications
  • Emergence of Integrated Pathology Workstations Optimizes End-to-End Diagnostic Workflows
  • Market Consolidation Among Device Manufacturers Spurs Innovation Through Strategic Acquisitions
  • Customization and Scalability Requirements Propel Demand for Modular Pathology Systems
  • Stringent Quality Control and Accreditation Norms Drive Adoption of Standardized Diagnostic Equipment
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Pathology Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Pathology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Pathology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Pathology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Clinical Chemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Clinical Chemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Clinical Chemistry Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Immunoassays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Immunoassays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Immunoassays Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Microbiology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Microbiology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Microbiology Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Molecular Diagnostics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Molecular Diagnostics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Molecular Diagnostics Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Pharmaceutical Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Pharmaceutical Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Pharmaceutical Companies End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Laboratories End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Hospitals & Diagnostic Laboratories End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Hospitals & Diagnostic Laboratories End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Drug Discovery & Development Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Disease Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Disease Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Disease Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Forensic Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Forensic Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Forensic Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• JAPAN
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Japan 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• CHINA
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: China 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: China 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: China 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• EUROPE
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Pathology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Pathology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Pathology Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Europe 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• FRANCE
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: France 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: France 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: France 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• GERMANY
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Germany 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Germany 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Germany 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Italy 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Italy 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Italy 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: UK 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: UK 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: UK 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Spain 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Spain 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Spain 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Russia 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Russia 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Russia 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Pathology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Pathology Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Australia 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Australia 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Australia 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• INDIA
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: India 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: India 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: India 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: South Korea 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: South Korea 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: South Korea 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Pathology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Pathology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Pathology Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Latin America 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Argentina 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Argentina 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Argentina 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Brazil 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Brazil 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Brazil 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Mexico 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Mexico 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Mexico 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Pathology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Pathology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Pathology Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Middle East 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Iran 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Iran 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Iran 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Israel 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Israel 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Israel 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: UAE 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: UAE 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: UAE 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• AFRICA
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Africa 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Africa 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Africa 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030

IV. COMPETITION